Latest Insider Transactions at Enhabit, Inc. (EHAB)
This section provides a real-time view of insider transactions for Enhabit, Inc. (EHAB). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Enhabit, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Enhabit, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 12
2024
|
Jeffrey Bolton Director |
BUY
Open market or private purchase
|
Direct |
4,000
+3.92%
|
$32,000
$8.69 P/Share
|
|
Dec 10
2024
|
Stuart M Mcguigan Director |
BUY
Open market or private purchase
|
Direct |
15,000
+24.27%
|
$120,000
$8.81 P/Share
|
|
Nov 12
2024
|
Jeffrey Bolton Director |
BUY
Open market or private purchase
|
Direct |
3,000
+3.09%
|
$21,000
$7.6 P/Share
|
|
Nov 08
2024
|
Jeffrey Bolton Director |
BUY
Open market or private purchase
|
Direct |
7,000
+3.64%
|
$49,000
$7.76 P/Share
|
|
Oct 10
2024
|
Mark W Ohlendorf Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,633
+13.27%
|
$18,431
$7.12 P/Share
|
|
Oct 10
2024
|
Barry P. Schochet Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,336
+7.73%
|
$23,352
$7.12 P/Share
|
|
Oct 10
2024
|
Gregory S Rush Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,511
+6.9%
|
$24,577
$7.12 P/Share
|
|
Oct 10
2024
|
Erin Hoeflinger Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,336
+6.46%
|
$23,352
$7.12 P/Share
|
|
Oct 10
2024
|
Charles M Elson Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,633
+4.82%
|
$18,431
$7.12 P/Share
|
|
Oct 10
2024
|
Stuart M Mcguigan Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,633
+7.64%
|
$18,431
$7.12 P/Share
|
|
Oct 10
2024
|
Jeffrey Bolton Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,267
+5.89%
|
$36,869
$7.12 P/Share
|
|
Aug 22
2024
|
Jeffrey Bolton Director |
BUY
Open market or private purchase
|
Direct |
5,000
+5.96%
|
$40,000
$8.01 P/Share
|
|
Aug 09
2024
|
Jeffrey Bolton Director |
BUY
Open market or private purchase
|
Direct |
5,000
+6.34%
|
$40,000
$8.29 P/Share
|
|
Aug 08
2024
|
Jeffrey Bolton Director |
BUY
Open market or private purchase
|
Direct |
2,000
+2.82%
|
$16,000
$8.6 P/Share
|
|
Jul 25
2024
|
Barry P. Schochet Director |
BUY
Grant, award, or other acquisition
|
Direct |
14,578
+28.54%
|
$145,780
$10.29 P/Share
|
|
Jul 25
2024
|
Charles M Elson Director |
BUY
Grant, award, or other acquisition
|
Direct |
14,578
+22.8%
|
$145,780
$10.29 P/Share
|
|
Jul 25
2024
|
Tina L. Brown Stevenson Director |
BUY
Grant, award, or other acquisition
|
Direct |
14,578
+28.31%
|
$145,780
$10.29 P/Share
|
|
Jul 25
2024
|
Jeffrey Bolton Director |
BUY
Grant, award, or other acquisition
|
Direct |
14,578
+17.9%
|
$145,780
$10.29 P/Share
|
|
Jul 25
2024
|
Stuart M Mcguigan Director |
BUY
Grant, award, or other acquisition
|
Direct |
14,578
+33.32%
|
$145,780
$10.29 P/Share
|
|
Jul 25
2024
|
Gregory S Rush Director |
BUY
Grant, award, or other acquisition
|
Direct |
14,578
+24.94%
|
$145,780
$10.29 P/Share
|
|
Jul 25
2024
|
Erin Hoeflinger Director |
BUY
Grant, award, or other acquisition
|
Direct |
14,578
+24.48%
|
$145,780
$10.29 P/Share
|
|
Jul 01
2024
|
Julie Diane Jolley EVP of Home Health Operations |
SELL
Payment of exercise price or tax liability
|
Direct |
1,302
-1.82%
|
$10,416
$8.75 P/Share
|
|
Jul 01
2024
|
Crissy Buchanan Carlisle Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,779
-2.01%
|
$14,232
$8.75 P/Share
|
|
Jul 01
2024
|
Ronald Leroy Langham Jr EVP Clinical Excel. & Strategy |
SELL
Payment of exercise price or tax liability
|
Direct |
673
-1.18%
|
$5,384
$8.75 P/Share
|
|
May 17
2024
|
Jeffrey Bolton Director |
BUY
Open market or private purchase
|
Direct |
10,000
+16.05%
|
$80,000
$8.33 P/Share
|
|
May 14
2024
|
Erin Hoeflinger Director |
BUY
Open market or private purchase
|
Direct |
2,000
+6.17%
|
$18,000
$9.0 P/Share
|
|
May 10
2024
|
Jeffrey Bolton Director |
BUY
Open market or private purchase
|
Direct |
10,000
+19.12%
|
$80,000
$8.24 P/Share
|
|
Mar 01
2024
|
Jeanne Louise Kalvaitis EVP of Hospice Operations |
SELL
Payment of exercise price or tax liability
|
Direct |
578
-4.98%
|
$4,624
$8.81 P/Share
|
|
Mar 01
2024
|
Jeanne Louise Kalvaitis EVP of Hospice Operations |
BUY
Grant, award, or other acquisition
|
Direct |
5,764
+33.18%
|
$46,112
$8.81 P/Share
|
|
Mar 01
2024
|
Tanya Renee Marion Chief Human Resources Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
772
-1.78%
|
$6,176
$8.81 P/Share
|
|
Mar 01
2024
|
Tanya Renee Marion Chief Human Resources Officer |
BUY
Grant, award, or other acquisition
|
Direct |
16,308
+27.3%
|
$130,464
$8.81 P/Share
|
|
Mar 01
2024
|
Ronald Leroy Langham Jr EVP Clinical Excel. & Strategy |
SELL
Open market or private sale
|
Direct |
634
-1.1%
|
$5,072
$8.81 P/Share
|
|
Mar 01
2024
|
Ronald Leroy Langham Jr EVP Clinical Excel. & Strategy |
BUY
Grant, award, or other acquisition
|
Direct |
15,027
+20.63%
|
$120,216
$8.81 P/Share
|
|
Mar 01
2024
|
Crissy Buchanan Carlisle Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,327
-1.48%
|
$10,616
$8.81 P/Share
|
|
Mar 01
2024
|
Crissy Buchanan Carlisle Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
18,144
+16.83%
|
$145,152
$8.81 P/Share
|
|
Mar 01
2024
|
Dylan C Black General Counsel and Secretary |
SELL
Payment of exercise price or tax liability
|
Direct |
910
-3.45%
|
$7,280
$8.81 P/Share
|
|
Mar 01
2024
|
Dylan C Black General Counsel and Secretary |
BUY
Grant, award, or other acquisition
|
Direct |
14,942
+36.16%
|
$119,536
$8.81 P/Share
|
|
Mar 01
2024
|
Julie Diane Jolley EVP of Home Health Operations |
SELL
Payment of exercise price or tax liability
|
Direct |
1,035
-1.43%
|
$8,280
$8.81 P/Share
|
|
Mar 01
2024
|
Julie Diane Jolley EVP of Home Health Operations |
BUY
Grant, award, or other acquisition
|
Direct |
18,144
+20.02%
|
$145,152
$8.81 P/Share
|
|
Mar 01
2024
|
Barbara Ann Jacobsmeyer President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
4,591
-0.97%
|
$36,728
$8.81 P/Share
|
|
Mar 01
2024
|
Barbara Ann Jacobsmeyer President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
114,302
+19.38%
|
$914,416
$8.81 P/Share
|
|
Feb 25
2024
|
Barbara Ann Jacobsmeyer President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
5,063
-1.38%
|
$45,567
$9.49 P/Share
|
|
Feb 25
2024
|
Crissy Buchanan Carlisle Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
767
-1.06%
|
$6,903
$9.49 P/Share
|
|
Feb 25
2024
|
Ronald Leroy Langham Jr EVP Clinical Excel. & Strategy |
SELL
Payment of exercise price or tax liability
|
Direct |
333
-0.77%
|
$2,997
$9.49 P/Share
|
|
Feb 25
2024
|
Julie Diane Jolley EVP of Home Health Operations |
SELL
Payment of exercise price or tax liability
|
Direct |
614
-1.12%
|
$5,526
$9.49 P/Share
|
|
Feb 25
2024
|
Tanya Renee Marion Chief Human Resources Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
346
-1.26%
|
$3,114
$9.49 P/Share
|
|
Feb 24
2024
|
Barbara Ann Jacobsmeyer President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
789
-0.21%
|
$7,101
$9.49 P/Share
|
|
Feb 24
2024
|
Crissy Buchanan Carlisle Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
205
-0.28%
|
$1,845
$9.49 P/Share
|
|
Feb 24
2024
|
Ronald Leroy Langham Jr EVP Clinical Excel. & Strategy |
SELL
Payment of exercise price or tax liability
|
Direct |
181
-0.42%
|
$1,629
$9.49 P/Share
|
|
Feb 24
2024
|
Julie Diane Jolley EVP of Home Health Operations |
SELL
Payment of exercise price or tax liability
|
Direct |
181
-0.33%
|
$1,629
$9.49 P/Share
|